Skip to content

Clinical Impact of Surgical Wound Morbidity According to the Type of Saphenous Vein Harvesting Technique (Endoscopic vs. Open) in Patients Undergoing Myocardial Revascularization Surgery

Endoscopic Saphenous Vein Harvesting Versus Conventional Open Harvesting in Patients Undergoing Coronary Artery Bypass Grafting, Either Alone or in Combination With Another Cardiac Surgical Procedure, in Terms of the Clinical Impact of Surgical Wound Morbidity

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07002658
Acronym
EndOSiC
Enrollment
356
Registered
2025-06-03
Start date
2025-07-01
Completion date
2026-08-01
Last updated
2025-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Use, CABG-patients, Cardiac Surgery, Coronary Artery Bypass Graft With or Without ECC, Endoscopic Surgery, Off Pump Coronary Artery Bypass Graft, Saphenectomy, Wound Complications

Keywords

endoscopic vein harvesting, CABG surgery, open vein harvesting, wound morbidity

Brief summary

The goal of this clinical trial is to compare two different techniques: endoscopic saphenous vein harvesting versus conventional open harvesting in patients undergoing coronary artery bypass grafting, either alone or in combination with another cardiac surgical procedure (valve surgery or arrhythmia surgery). The main questions the trial aims to answer are: Does the endoscopic technique reduce surgical wound morbidity in terms of shorter hospital stays? Does endoscopic saphenous harvesting reduce the use of antibiotics for saphenectomy wound infections? Does the endoscopic technique reduce need for wound dressings due to necrosis and/or wound infection, and reduce need for analgesic treatment for wound pain? This prospective, randomized study will be conducted in the Cardiovascular Surgery Service at Hospital Clínico San Carlos. Participants will be randomly assigned to a different saphenectomy technique. All patients will be assessed for saphenectomy wound complications upon discharge, and by phone call at 7 days, 1 month, and 3 months following the intervention.

Detailed description

* Pain in the leg incisions will be assessed using a standarized pain scale. * Antibiotic and analgesic requirements for infection or pain in the saphenous vein surgical wound will be documeted. * The need for outpatient treatment or hospitalization due to surgical wounds will be evaluated. * A surgical wound cosmetic satisfaction survey will be administered to participants. * Images of the saphenectomy surgical wound will be collected at 1 month postoperatively. * Major cardiovascular events will be monitored during follow-up visits or hospital admissions and recorded in the RECC database (local service database)

Interventions

PROCEDUREHarvesting of the saphenous vein graft

Most existing studies on endoscopic saphenectomy have been conducted in CABG with cardiopulmonary bypass (CBP), whereas most CABG surgeries at the study center are performed without CBP. The following outcomes will be identified: * Days of admission or need for hospitalization * Use of antibiotic therapy for saphenectomy wound infections * Need for wound dressings due to necrosis and/or wound infection * Need for analgesic treatment for wound pain

Sponsors

Hospital San Carlos, Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

One group will receive the open technique for saphenous vein harvesting and the other group will receive the endoscopic technique.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing coronary artery bypass grafting (CABG), alone or in combination with other surgery (valve or arrhythmia surgery), with or without cardiopulmonary bypass (CPB), in which preoperative evaluation includes the plan to use a short saphenous vein segment (alone or in addition to arterial conduits). * Availability of a surgeon or cardiac surgery resident trained in endoscopic harvesting in the operating room. * Patients undergoing myocardial revascularization surgeries with or without extracorporeal circulation. * Patients undergoing concomitant cardiac valve replacement surgery, atrial fibrillation surgery, and others, in addition to CABG

Exclusion criteria

* Emergent surgery or procedures performed during cardiorespiratory arrest * Myocardial revascularization with arterial grafts only * Presence of varicose veins * History of infrainguinal vascular surgery * Presence of ulcers and/or active infection in the lower limbs * Previous stroke with neurological sequelae in the legs * History of deep vein thrombosis in the legs * Pregnancy * Age under 18 years * Lack of signed informed consent

Design outcomes

Primary

MeasureTime frameDescription
Wound morbidityFrom enrollment to the three-month follow-up visitDays of hospital stay, use of antibiotics for saphenectomy wound infections, need for wound dressings due to necrosis and/or wound infection, and need for analgesic treatment for wound pain. 1. Length of Hospital Stay. Unit of Measure: Days 2. Use of Antibiotics for Saphenectomy Wound Infections Measure: Number of participants requiring oral or parenteral antibiotics due to wound infection. Unit of Measure: Participants 3. Need for Wound Dressings Due to Necrosis and/or Infection Measure: Number of participants requiring wound dressings due to necrosis and/or wound infection. Unit of Measure: Participants 4. Use of Analgesics for Wound Pain Measure: Number of participants requiring analgesic treatment for saphenectomy wound pain

Secondary

MeasureTime frameDescription
Freedom from combined cardiac events1 yearFreedom from death, myocardial infarction, and recurrent angina

Countries

Spain

Contacts

Primary ContactMaría B Solís Chávez, MD
mabesolis95@gmail.com+34613888798

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026